Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial.
de Boer N, Guloksuz S, van Baal C, Willebrands L, Deenik J, Vinkers CH, Rossum IW, Zinkstok J, Wilting I, Zantvoord JB, Backx F, Swildens WE, Schouw M, Bogers J, Hulshof F, de Knijff R, Duindam P, Veereschild M, Bak M, Frederix G, de Haan L, van Os J, Cahn W, Luykx JJ. de Boer N, et al. Among authors: rossum iw. BMC Psychiatry. 2021 Jan 5;21(1):4. doi: 10.1186/s12888-020-02992-4. BMC Psychiatry. 2021. PMID: 33402159 Free PMC article.
Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses.
Troudet R, Ali WBH, Bacq-Daian D, Rossum IWV, Boland-Auge A, Battail C, Barau C; OPTiMiSE study group; Rujescu D, McGuire P, Kahn RS, Deleuze JF, Leboyer M, Jamain S. Troudet R, et al. Neuropsychopharmacology. 2020 Sep;45(10):1637-1644. doi: 10.1038/s41386-020-0703-2. Epub 2020 May 25. Neuropsychopharmacology. 2020. PMID: 32450569 Free PMC article.
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
Leucht S, Rossum IW, Heres S, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leweke FM, Lewis S, McGuire P, Meyer-Lindenberg A, Rujescu D, Kapur S, Kahn RS, Sommer IE. Leucht S, et al. Among authors: rossum iw. Focus (Am Psychiatr Publ). 2016 Jul;14(3):378-386. doi: 10.1176/appi.focus.140302. Epub 2016 Jul 8. Focus (Am Psychiatr Publ). 2016. PMID: 31997959 Free PMC article.
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients.
Jongs N, Penninx B, Arango C, Ayuso-Mateos JL, van der Wee N, Rossum IW, Saris IMJ, van Echteld A, Koops S, Bilderbeck AC, Raslescu A, Dawson GR, Sommer B, Marston H, Vorstman JA, Eijkemans MJ, Kas MJ. Jongs N, et al. Among authors: rossum iw. J Psychiatr Res. 2022 Jan;145:302-308. doi: 10.1016/j.jpsychires.2020.11.013. Epub 2020 Nov 9. J Psychiatr Res. 2022. PMID: 33221026 Free article.
Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders.
de la Torre-Luque A, Viera-Campos A, Bilderbeck AC, Carreras MT, Vivancos J, Diaz-Caneja CM, Aghajani M, Saris IMJ, Raslescu A, Malik A, Clark J, Penninx BWJH, van der Wee N, Rossum IW, Sommer B, Marston H, Dawson GR, Kas MJ, Ayuso-Mateos JL, Arango C. de la Torre-Luque A, et al. Among authors: rossum iw. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 8;113:110463. doi: 10.1016/j.pnpbp.2021.110463. Epub 2021 Oct 27. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 34718073
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, Cecci G, Chen EYH, Cho KIK, Choi J, Clark SR, Coleman MJ, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Dwyer D, Ebdrup BH, Ellman LM, Fusar-Poli P, Galindo L, Gaspar PA, Gerber C, Glenthøj LB, Glynn R, Harms MP, Horton LE, Kahn RS, Kambeitz J, Kambeitz-Ilankovic L, Kane JM, Kapur T, Keshavan MS, Kim SW, Koutsouleris N, Kubicki M, Kwon JS, Langbein K, Lewandowski KE, Light GA, Mamah D, Marcy PJ, Mathalon DH, McGorry PD, Mittal VA, Nordentoft M, Nunez A, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR 3rd, Roalf DR, Sabb FW, Schiffman J, Shah JL, Smesny S, Spark J, Stone WS, Strauss GP, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum IW, Wolf DH, Wolff P, Wood SJ, Yung AR, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión RE, Castro E, Cetin-Karayumak S, Mallar Chakravarty M, Cho YT, Cotter D, D'Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur RE, Gur RC, Hamilton HK, Hoftman GD, Jacobs GR, Jarcho J, Ji JL, Kohler CG, Lalo… See abstract for full author list ➔ Wannan CMJ, et al. Among authors: rossum iw. Schizophr Bull. 2024 Apr 30;50(3):496-512. doi: 10.1093/schbul/sbae011. Schizophr Bull. 2024. PMID: 38451304 Free PMC article.
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort.
Slot MIE, van Hell HH, Rossum IW, Dazzan P, Maat A, de Haan L, Crespo-Facorro B, Glenthøj B, Lawrie SM, McDonald C, Gruber O, van Amelsvoort T, Arango C, Kircher T, Nelson B, Galderisi S, Weiser M, Sachs G, Maatz A, Bressan RA, Kwon JS, Mizrahi R; PSYSCAN Consortium; McGuire P, Kahn RS. Slot MIE, et al. Among authors: rossum iw. Schizophr Res. 2024 Apr;266:237-248. doi: 10.1016/j.schres.2024.02.018. Epub 2024 Mar 2. Schizophr Res. 2024. PMID: 38431986 Free article.
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.
Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Marcy PJ, Allott K, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EYH, Choi J, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Kapur T, Keshavan MS, Koutsouleris N, Langbein K, Lavoie S, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pasternak O, Pearlson GD, Gaspar PA, Shah JL, Smesny S, Stone WS, Strauss GP, Wang J, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR 3rd, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR; Accelerating Medicines Partnership Schizophrenia. Woods SW, et al. Early Interv Psychiatry. 2024 Apr;18(4):255-272. doi: 10.1111/eip.13457. Epub 2023 Aug 28. Early Interv Psychiatry. 2024. PMID: 37641537
Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic study.
Braak S, Su T, Krudop W, Pijnenburg YAL, Reus LM, van der Wee N, Bilderbeck AC, Dawson GR, van Rossum IW, Campos AV, Arango C, Saris IMJ, Kas MJ, Penninx BWJH. Braak S, et al. Among authors: van rossum iw. Eur Neuropsychopharmacol. 2022 Nov;64:19-29. doi: 10.1016/j.euroneuro.2022.08.005. Epub 2022 Sep 5. Eur Neuropsychopharmacol. 2022. PMID: 36070667 Free article.
13 results